Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kaserer A"'
Publikováno v:
Kidney International. 70(11):2014-2020
It is currently not known which level of pentagastrin-stimulated calcitonin serum concentration indicates medullary thyroid carcinoma in patients with chronic kidney disease (CKD). We examined CKD stage 3-5 patients who had total thyroidectomy becaus
Publikováno v:
Europe PubMed Central
The prevalence of thyroid C-cell hyperplasia (CCH) was investigated prospectively in 57 patients with normal preoperative pentagastrin-stimulated plasma concentrations of calcitonin (hCT, range, 1-60 pg/mL; normal, 100 pg/mL) who subsequently underwe
Autor:
Bruno Niederle, Christian Scheuba, Martin Lauss, Albert Kriegner, Oskar A. Haas, Klemens Vierlinger, Klaus Kaserer, Andreas Weinhaeusel
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 18(12)
Background RET germline mutations predispose to the development of hereditary medullary thyroid carcinoma (hMTC). Several single nucleotide polymorphisms (SNPs) are described associated with sporadic MTC (sMTC). However, the findings regarding their
Autor:
A. Schmidt, H. Kotzmann, G. Söregi, B. Watschinger, Heinrich Vierhapper, Bruno Niederle, Christian Scheuba, Klaus Kaserer
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 9(9)
Plasma concentrations of calcitonin (hCT) were determined in 150 patients with chronic renal failure on chronic hemodialysis therapy (CHD) and in 800 patients after successful kidney transplantation (KT). Basal hCT concentrations exceeded 10 pg/mL in
Autor:
A. Weinhäusl, Klaus Kaserer, Wolfgang Raber, Christian Bieglmayer, Bruno Niederle, Heinrich Vierhapper
Publikováno v:
The Journal of clinical endocrinology and metabolism. 82(5)
In a prospective study, plasma concentrations of human calcitonin (hCT) were determined in 1062 consecutive patients with thyroid nodular disease. Basal plasma hCT was above the normal range (>6 pg/mL) in 55 patients and was elevated up to more than